Advances in fluorescent probe technology could allow real-time visualization of cancer progression during surgery

Advances in fluorescent probe technology could allow real-time visualization of cancer progression during surgery
The metastasized lymph node (top) of a mouse injected with the probe shows lower fluorescence signal intensity than a normal lymph node (bottom). Credit: Jung Sun Yoo, National University of Singapore

In order to determine the best treatment for patients affected by cancer, it is crucial for physicians to identify how the disease is spreading via lymph nodes in the body—a process known as metastasis. Progression of the disease is currently monitored by dissecting lymph nodes during surgery and subsequently performing biopsies. However, using a more sensitive and accurate method that is less invasive based on optical imaging technologies to visualize disease progression in situ could further improve cancer patient diagnoses and limit the time that they are required to spend in surgery.

Now, Young-Tae Chang and co-workers at the A*STAR Singapore Bioimaging Consortium, together with Jung Sun Yoo and researchers at the National University of Singapore, have developed a novel that is capable of infiltrating lymph nodes and highlighting cancer progression. The probe could potentially be used to provide information for making rapid diagnoses during surgery.

"Immune cells in lymph nodes, such as macrophages, have a novel role in ," explains Yoo. "We wanted to find a macrophage-targeting fluorescent probe that could distinguish metastasized lymph nodes from inflamed or normal lymph nodes."

The team sifted through many libraries of fluorochromes—small nontoxic organic molecules suitable for intraoperative imaging—while searching for those that could specifically stain macrophages. Flow cytometry and testing with human blood samples allowed the researchers to select the best fit for their fluorescent probe.

"We then used the probe for in vivo mouse imaging," explains Yoo. "This tested whether the probe could pinpoint the sentinel lymph node—the first node to drain a tumor and potentially initiate cancer spreading through the body." Following injection, the team's probe immediately accumulated in the of the mouse, with bright signals in inflamed nodes and less bright signals in metastasized nodes (see image).

The new has several potential biomedical applications. Researchers could use it to investigate the behavior of macrophages in in vivo. Surgeons could obtain real-time information on the infiltration of tumors and how far the disease has spread while a patient is still in surgery, eliminating the need for pre-operative biopsies and minimizing the potential for further surgical procedures.

"We also hope to develop macrophage probes with near-infrared for better depth penetration, as well as subset-specific agents capable of differentiating between 'good' and 'bad' macrophages in many different diseases," states Yoo. "Subtype-specific fluorochromes will have a high impact on the future of clinical imaging."

More information: Yoo, J. S., Lee, S.-C., Jow, Z. Y., Koh, P. Y. X. & Chang, Y.-T. "A macrophage-specific fluorescent probe for intraoperative lymph node staging." Cancer Research 74, 44–55 (2014). dx.doi.org/10.1158/0008-5472.CAN-13-2129

add to favorites email to friend print save as pdf

Related Stories

Lymphoseek approved to help locate lymph nodes

Mar 13, 2013

(HealthDay)—The injected imaging drug Lymphoseek (technetium Tc 99m tilmanocept) has been approved by the U.S. Food and Drug Administration to help surgeons locate the lymph nodes among people with breast cancer or melanoma.

Recommended for you

Researcher to cancer: 'Resistance will be futile'

25 minutes ago

Turning the tables, Katherine Borden at the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) has evoked Star Trek's Borg in her fight against the disease. "Cancer cells rapidly ...

How does prostate cancer form?

2 hours ago

Prostate cancer affects more than 23,000 men this year in the USA however the individual genes that initiate prostate cancer formation are poorly understood. Finding an enzyme that regulates this process ...

Low risk of malignancy for small complex adnexal masses

9 hours ago

(HealthDay)—For older women with small complex adnexal masses, the overall risk of malignancy is low, according to a study published in the December issue of the American Journal of Obstetrics & Gynecology.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.